TY - JOUR
T1 - Psychopharmacology in Cancer
AU - Thekdi, Seema M.
AU - Trinidad, Antolin
AU - Roth, Andrew
N1 - Publisher Copyright:
© 2014, Springer Science+Business Media New York.
PY - 2014/1
Y1 - 2014/1
N2 - Depression, anxiety, delirium, and other psychiatric symptoms are highly prevalent in the cancer setting, and pharmacological intervention is an important component in the overall psychosocial care of the patient. Psychopharmacology is also used as a primary or adjuvant treatment for the management of cancer-related symptoms stemming from the disease itself and/or its treatment, including sleep disturbance, loss of appetite, neuropathic pain, nausea, fatigue, and hot flashes. Psychiatrists, oncologists, and palliative care physicians working as members of a multidisciplinary team have the opportunity to target multiple symptoms that negatively affect a patient’s quality of life with the strategic use of psychotropic medications when deemed appropriate. This article aims to review the indications for use of antidepressants, psychostimulants, anxiolytics, antipsychotics, and mood stabilizers in oncology. An updated review of the relevant literature is discussed and referenced in each section.
AB - Depression, anxiety, delirium, and other psychiatric symptoms are highly prevalent in the cancer setting, and pharmacological intervention is an important component in the overall psychosocial care of the patient. Psychopharmacology is also used as a primary or adjuvant treatment for the management of cancer-related symptoms stemming from the disease itself and/or its treatment, including sleep disturbance, loss of appetite, neuropathic pain, nausea, fatigue, and hot flashes. Psychiatrists, oncologists, and palliative care physicians working as members of a multidisciplinary team have the opportunity to target multiple symptoms that negatively affect a patient’s quality of life with the strategic use of psychotropic medications when deemed appropriate. This article aims to review the indications for use of antidepressants, psychostimulants, anxiolytics, antipsychotics, and mood stabilizers in oncology. An updated review of the relevant literature is discussed and referenced in each section.
KW - Anxiety
KW - Cancer
KW - Cancer-related symptoms
KW - Depression
KW - Psycho-oncology
KW - Psychopharmacology
UR - http://www.scopus.com/inward/record.url?scp=84912076730&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84912076730&partnerID=8YFLogxK
U2 - 10.1007/s11920-014-0529-x
DO - 10.1007/s11920-014-0529-x
M3 - Review article
C2 - 25417593
AN - SCOPUS:84912076730
SN - 1523-3812
VL - 17
JO - Current Psychiatry Reports
JF - Current Psychiatry Reports
IS - 1
ER -